Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers

Sara G. Manore(Wake Forest University), Hui‐Wen Lo(The University of Texas MD Anderson Cancer Center)

Cells

December 17, 2024

10.3390/cells13242087

Cited by 1

Related Papers

TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment

|Oncogene|2019|87

Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis

|Oncogene|2020|83

Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth

|Oncotarget|2017|44

HER2 Phosphorylates and Destabilizes Pro-Apoptotic PUMA, Leading to Antagonized Apoptosis in Cancer Cells

|PLoS ONE|2013|19